<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03413267</url>
  </required_header>
  <id_info>
    <org_study_id>MicroNut</org_study_id>
    <secondary_id>2017-A01996-47</secondary_id>
    <nct_id>NCT03413267</nct_id>
  </id_info>
  <brief_title>Impact of Food Structure on Micronutrient Bioavailability in Human</brief_title>
  <official_title>Impact of Food Structure on Micronutrient Biovailability in Human</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Françoise Nau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre de Recherche en Nutrition Humaine d'Auvergne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université d'Auvergne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Recherche Agronomique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The nutritional quality of foods strongly depends on the structure / texture of foods,&#xD;
      because of the impact on food disintegration, and then on digestion process and nutrient&#xD;
      utilization by the human body. However, this relationship between food structure and nutrient&#xD;
      bioavailability is still widely unknown.&#xD;
&#xD;
      MicroNut project aims at demonstrating and evaluating in humans the impact of structure /&#xD;
      texture changes on micronutrient bioavailability. In order to do this, four complex food&#xD;
      matrices, with constant composition but different structures / textures, and as close as&#xD;
      possible to real foods have been designed and are evaluated in the present study. A mixture&#xD;
      of egg and plant proteins is the basis of these lipoprotein matrices in which four&#xD;
      micronutrients will be followed up : two lipophilic (vitamin D and lutein) and 2 hydrophilic&#xD;
      (vitamins B9 and B12).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective consists in understanding how food structure / texture impacts on&#xD;
      micronutrient bioavailability. The second objective consists in studying food disintegration&#xD;
      at oral phase (in the mouth) and the consequences on the bioaccessibility of hydrophilic&#xD;
      vitamins in saliva.&#xD;
&#xD;
      The clinical study is open, monocentric, controled and randomized, in a cross experimental&#xD;
      design.&#xD;
&#xD;
      The included volunteers (n=12) will participate in the whole two protocols. The first&#xD;
      protocol is related to the study of vitamins B9, B12, D and lutein bioavailability during 8h&#xD;
      kinetics, after ingestion of a food matrix (custard, biscuit, flan or sponge cake). The&#xD;
      second protocol is related to the study of hydrophilic vitamin release during mastication of&#xD;
      two of these matrices (biscuit and sponge cake).&#xD;
&#xD;
      The study is not performed in a double blind way. However, the measure bias will be limited&#xD;
      because of the standardized and objective characteristic of the main criteria. Moreover,&#xD;
      biological samples will be analysed by the same partners of the project. Each subject will be&#xD;
      his own control, so that confusion factors related to individual variability will be&#xD;
      eliminated.&#xD;
&#xD;
      The monocentric characteristic of the study, the low number of subjects and the expertise of&#xD;
      the involved staff will enable to limit the number of missing data.&#xD;
&#xD;
      The randomization (latin square) has been established by a bio-statistician of the project&#xD;
      before the study started. A document describing the randomization proceeding is&#xD;
      confidentially kept.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 7, 2017</start_date>
  <completion_date type="Actual">April 19, 2018</completion_date>
  <primary_completion_date type="Actual">April 19, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Bioavailability protocol : each volunteer participates in 4 interventions (4 food matrices), during 4 different days (one food matrix per day). At least 3 weeks between each intervention day. An intervention consists in food matrix ingestion (t=0) and blood sampling for 8 h postprandial (10 sampling times).&#xD;
Mastication protocol : each volunteer participates in 1 session during which 2 solid matrices will be studied. For each matrix, 13 samples are proposed to the volunteer; food bolus are collected just before the volunteer feels the need of swallowing.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Because the food matrices ingested by the volunteers have different aspects, no masking is really possible. However, blood samples will be analyzed by partners without knowledge of the matrix that has been ingested.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Quantitative analysis of vitamin D, B9, B12 and lutein in blood</measure>
    <time_frame>8 hours</time_frame>
    <description>Blood sampling before (T-30min to determine basal concentrations) and after food matrix ingestion (T0) for 8 h postprandial (10 sampling between 30 and 480min postprandial) for vitamin D, B9, B12 and lutein measurement in plasma; vitamin D and lutein will be quantified by HPLC-DAD in the chylomicron fraction; vitamin B9 and B12 will be quantified by ELISA method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantitative analysis of vitamin B9 and B12 in the liquid fraction of food boluses and characterization of these boluses</measure>
    <time_frame>one and half hour</time_frame>
    <description>Normal mastication of food matrix and splitting out for characterization of food bolus: granulometry, rheology and vitamin B9 and B12 release in the liquid fraction (saliva + food water + rinsing water); each volunteer successively masticates 13 samples of each solid food matrix (biscuit and sponge cake); vitamin B9 and B12 will be quantified by ELISA method</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Food Structure Impact on Micronutrient Bioavailability</condition>
  <arm_group>
    <arm_group_label>Custard</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The food matrix ingested (once by each volunteer) is a custard containing 1250µg vitamin D (=50 000 UI), 12µg vitamin B12, 1000µg vitamin B9 and 20 mg lutein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The food matrix ingested (once by each volunteer) is a flan containing 1250µg vitamin D (=50 000 UI), 12µg vitamin B12, 1000µg vitamin B9 and 20 mg lutein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sponge cake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The food matrix ingested (once by each volunteer) is a sponge cake containing 1250µg vitamin D (=50 000 UI), 12µg vitamin B12, 1000µg vitamin B9 and 20 mg lutein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biscuit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The food matrix ingested (once by each volunteer) is biscuits containing 1250µg vitamin D (=50 000 UI), 12µg vitamin B12, 1000µg vitamin B9 and 20 mg lutein</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Custard</intervention_name>
    <description>Food matrix: custard (liquid emulsion)</description>
    <arm_group_label>Custard</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flan</intervention_name>
    <description>Food matrix: flan (soft gel)</description>
    <arm_group_label>Flan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sponge cake</intervention_name>
    <description>Food matrix: sponge cake (porous and spongy)</description>
    <arm_group_label>Sponge cake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biscuit</intervention_name>
    <description>Food matrix: biscuit (thick and crunchy)</description>
    <arm_group_label>Biscuit</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  no smoking since 6 months at least&#xD;
&#xD;
          -  no pathology and no medical treatment&#xD;
&#xD;
          -  no history of calcium lithiasis&#xD;
&#xD;
          -  BMI &gt;=20 and &lt;=30 kg/m²&#xD;
&#xD;
          -  normal biological status&#xD;
&#xD;
          -  no dislike for the food tested&#xD;
&#xD;
          -  good dental health, no pain, no treatment in progress, no orthodontics since 3 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hypercalcemia (&gt;2.52 mmol/L), hyperphosphoremia (&gt;1.58 mmol/L)&#xD;
&#xD;
          -  known pathology&#xD;
&#xD;
          -  allergy or intolerance to one of the food matrix components (egg, vitamins B12, B9, D,&#xD;
             lutein, pea, gluten)&#xD;
&#xD;
          -  intake of food supplements and/or UVdose for the 3 months before the study, except&#xD;
             enriched foods&#xD;
&#xD;
          -  exposure to UV during the 2 weeks before the study and all along the study&#xD;
&#xD;
          -  vitamin D &lt; 80µg/L&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruddy Richard, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche en Nutrition Humaine d'Auvergne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de Recherche en Nutrition HUmaine d'Auvergne</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>January 22, 2018</study_first_submitted>
  <study_first_submitted_qc>January 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2018</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Institut National de la Recherche Agronomique</investigator_affiliation>
    <investigator_full_name>Françoise Nau</investigator_full_name>
    <investigator_title>PhD, Professor</investigator_title>
  </responsible_party>
  <keyword>micronutrient</keyword>
  <keyword>bioavailability</keyword>
  <keyword>bioaccessibility</keyword>
  <keyword>food structure</keyword>
  <keyword>food texture</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>De-identified individual participant data for all outcome measures will be made available, only after joined consent of promotor and investigator. Data use and transfer to a third party will be performed according to the agreement signed as part of the grant funded by Qualiment</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

